MediWound Ltd

NASDAQ: MDWD
Share price (4/25/24): $17.66
Market cap (4/25/24): $168 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

ended 12/31/19 FY 2019

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Updated info for already-effective prospectus

Additional exhibits for registration

Prospectus supplement

Ownership Filter

Rosalind Advisors, Inc.

Rosalind Advisors, Inc.

Deep Insight Limited Partnership

Israel Biotech Fund II, L.P.

Access Industries Holdings LLC

News Filter

Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Announces Positive Results in Head-To-Head Comparison of EscharEx® vs. SANTYL® Within the ChronEx Phase II Randomized Controlled Study

Announces That FDA Has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients With Severe Thermal Burns

Investor Presentation

Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness